-
EVAX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
Evaxion Biotech A/S (EVAX)
Company Profile
Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 5 |
Closed positions | 0 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.73 bn |
Total shares | 8.27 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MRK Merck & Co. | 7.72 mm | $21.31 mm |
Armistice Capital | 483.00 k | $1.50 bn |
Invst | 43.20 k | $134.35 mm |
Citadel Advisors | 14.83 k | $46.11 mm |
Beacon Capital Management | 4.86 k | $15.12 mm |
BlackRock | 1.51 k | $4.70 mm |
JPM JPMorgan Chase & Co. | 780.00 | $2.43 mm |
Rhumbline Advisers | 290.00 | $901.00 k |
SSB SouthState | 4.00 | $12.00 k |
Proequities | 0.00 | $0.00 |